Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer
Open Access
- 30 April 2008
- journal article
- research article
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 8 (1) , 17
- https://doi.org/10.1186/1472-6882-8-17
Abstract
Complementary and alternative medicine (CAM) use is well documented among breast cancer patients and survivors, but little evidence is available to describe rates and patterns of use among women at increased genetic risk of breast cancer.This publication has 32 references indexed in Scilit:
- Complementary and Alternative Medicine Use Among Breast Cancer SurvivorsThe Journal of Alternative and Complementary Medicine, 2007
- Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancerComplementary Therapies in Medicine, 2007
- Complementary Medicine Use before and 1 Year Following Genetic Testing for BRCA1/2 MutationsCancer Epidemiology, Biomarkers & Prevention, 2006
- Prevention and Management of Hereditary Breast CancerJournal of Clinical Oncology, 2005
- Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and deathBreast Cancer Research and Treatment, 2005
- Depression and the use of complementary medicine among breast cancer patientsSupportive Care in Cancer, 2004
- Bilateral Prophylactic Oophorectomy and Ovarian Cancer Screening Following BRCA1/BRCA2 Mutation TestingJournal of Clinical Oncology, 2003
- Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physiciansSupportive Care in Cancer, 2002
- Prophylactic Surgery Decisions and Surveillance Practices One Year Following BRCA1/2 TestingPreventive Medicine, 2000
- The CES-D ScaleApplied Psychological Measurement, 1977